{"id":832297,"date":"2025-04-01T09:37:05","date_gmt":"2025-04-01T13:37:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-to-participate-in-upcoming-investor-conference-5\/"},"modified":"2025-04-01T09:37:05","modified_gmt":"2025-04-01T13:37:05","slug":"recursion-to-participate-in-upcoming-investor-conference-5","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-to-participate-in-upcoming-investor-conference-5\/","title":{"rendered":"Recursion to Participate in Upcoming Investor Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>Salt Lake City, UT, April  01, 2025  (GLOBE NEWSWIRE) &#8212; Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today its participation in the following upcoming investor conference:<\/p>\n<ul>\n<li>\n          <strong>Needham 24th Annual Virtual Healthcare Conference <\/strong>\u2014 Monday, April 7, 2025<\/li>\n<\/ul>\n<p>Webcasts may be found in the events section of the Recursion Investor Relations website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HifsC_dQvSGVOb5MoBmafiURj_ezB7oiHYM7ZwwGo1Zxld3EKtugNuBVnXsQr_mA6Ap7FqkDr14KY0ZB2xHbXPms_cbzL6VsspXK9ovE97w=\" rel=\"nofollow\" target=\"_blank\"><u>ir.recursion.com<\/u><\/a>. <\/p>\n<p>\n        <strong>About Recursion<\/strong><br \/>\n        <br \/>Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world\u2019s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale \u2014 up to millions of wet lab experiments weekly \u2014 and massive computational scale \u2014 owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.<br \/>Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montr\u00e9al, New York, London, Oxford area, and the San Francisco Bay area. Learn more at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CBUTdT8TtFeY8uB1KCo0l9ORs8bpvBb8gMuJEJ2x5g7Egff7pTNwepXadwpDLNlDKJBXh8LEGiS8EjZBSUcrBtcK4SCBWeBskeJNN6K14SLYwPgTZ4SzBY2OSW89jbDrROKKsIg7a82HiUDbwFLuNhOoPcAo3gaLJf1Y7hKBekmFtj7SSDdtnpZ9xtpBKbsL3Qf8anWL7kVhjrkS1pJINEyddNhXlxrTsatjINmDtX7FBwP7U0UvCba5x8nhS90_t0S4gGFC3-UrQMm6vxfVgCigVOgL3o_YySBABQ8kHG7cjHqupPFxI2z2aBQBZFZhl9bOjhYq_AO8gz3FADRoc5WbzrbakVcBY674LG1w6smGBCTscse_SKcEkeyC-oDLfnouCFKULwhFkBATueZnmjRt0zgPycdt08TwI7dD1GfyT3OMfXWWNIBDLnHIzvQqhGb7J7KlfnIR0U7Vg5YlgyXUtb87Tgwdt1M7kSK5cQw=\" rel=\"nofollow\" target=\"_blank\">www.Recursion.com<\/a>, or connect on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=x5umXt83hG3-gbhCyfYUZvfoMChyeU89IQQTAAlbRU3YBwR-MfFA1vQO3MIV_wVsUe3A39LMrojjMGpAg5JzfZbxeUc9JS-R8my4OjtxTim2fNeXlM6X7nfmzbCYWT2JbhxiFdOMyLW052_toznEFYR3O7zcS1CKw0AVZMthQqjL6RWs4EYLNBIjYXjJWt9QqZ2zBM09H6kSgFVTHnuq8yshr7ziwzU-xDD5MTZ1J09ONJ2aUHn7Nc-OdkMU-WwLBQz9DW7ptQfaHR5q8EntrQ==\" rel=\"nofollow\" target=\"_blank\">X (formerly Twitter)<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=x0SEaQOA6QAw6aAF-pjjSmPpJlc5WqeXb4_lnsQJyTB2q1uYwve8IqpOOB_4tnF2yK3v8iFDDtJgEp6CbJuQXQBwqrdoCGeSKw0pPfe5UYUAnlHoMOANYjKeAryl8cgsv-1jEDyD654EBBXzd737tOImJ18znHG7qD37fMrKbLsv8R4DcBzpPA7WiPq6unBaelQJ97yqVfQPVF_ogPUay2eAbjVGGgb8q9GPo4gj_2xG1_NF2BrJ-0Eaq1mmy2wCn0SeRZmstmcrC6w7HEyksw==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNDQxMSM2ODQ0MTA5IzIyNTY0MTY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/N2JiNTkwNzMtY2YxZi00MDIzLTg4MDctYjZlYjdmMzA3OTIyLTEyNjc5NjUtMjAyNS0wNC0wMS1lbg==\/tiny\/Recursion-Pharmaceuticals.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Media Contact\r\nMedia@Recursion.com\r\n\r\nInvestor Contact\r\nInvestor@Recursion.com\r\n<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Salt Lake City, UT, April 01, 2025 (GLOBE NEWSWIRE) &#8212; Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today its participation in the following upcoming investor conference: Needham 24th Annual Virtual Healthcare Conference \u2014 Monday, April 7, 2025 Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com. About Recursion Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world\u2019s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-to-participate-in-upcoming-investor-conference-5\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Recursion to Participate in Upcoming Investor Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-832297","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Recursion to Participate in Upcoming Investor Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-to-participate-in-upcoming-investor-conference-5\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Recursion to Participate in Upcoming Investor Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Salt Lake City, UT, April 01, 2025 (GLOBE NEWSWIRE) &#8212; Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today its participation in the following upcoming investor conference: Needham 24th Annual Virtual Healthcare Conference \u2014 Monday, April 7, 2025 Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com. About Recursion Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world\u2019s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a &hellip; Continue reading &quot;Recursion to Participate in Upcoming Investor Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-to-participate-in-upcoming-investor-conference-5\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-01T13:37:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNDQxMSM2ODQ0MTA5IzIyNTY0MTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-to-participate-in-upcoming-investor-conference-5\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-to-participate-in-upcoming-investor-conference-5\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Recursion to Participate in Upcoming Investor Conference\",\"datePublished\":\"2025-04-01T13:37:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-to-participate-in-upcoming-investor-conference-5\\\/\"},\"wordCount\":235,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-to-participate-in-upcoming-investor-conference-5\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNDQxMSM2ODQ0MTA5IzIyNTY0MTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-to-participate-in-upcoming-investor-conference-5\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-to-participate-in-upcoming-investor-conference-5\\\/\",\"name\":\"Recursion to Participate in Upcoming Investor Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-to-participate-in-upcoming-investor-conference-5\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-to-participate-in-upcoming-investor-conference-5\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNDQxMSM2ODQ0MTA5IzIyNTY0MTY=\",\"datePublished\":\"2025-04-01T13:37:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-to-participate-in-upcoming-investor-conference-5\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-to-participate-in-upcoming-investor-conference-5\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-to-participate-in-upcoming-investor-conference-5\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNDQxMSM2ODQ0MTA5IzIyNTY0MTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxNDQxMSM2ODQ0MTA5IzIyNTY0MTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/recursion-to-participate-in-upcoming-investor-conference-5\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Recursion to Participate in Upcoming Investor Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Recursion to Participate in Upcoming Investor Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-to-participate-in-upcoming-investor-conference-5\/","og_locale":"en_US","og_type":"article","og_title":"Recursion to Participate in Upcoming Investor Conference - Market Newsdesk","og_description":"Salt Lake City, UT, April 01, 2025 (GLOBE NEWSWIRE) &#8212; Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today its participation in the following upcoming investor conference: Needham 24th Annual Virtual Healthcare Conference \u2014 Monday, April 7, 2025 Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com. About Recursion Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world\u2019s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a &hellip; Continue reading \"Recursion to Participate in Upcoming Investor Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-to-participate-in-upcoming-investor-conference-5\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-01T13:37:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNDQxMSM2ODQ0MTA5IzIyNTY0MTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-to-participate-in-upcoming-investor-conference-5\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-to-participate-in-upcoming-investor-conference-5\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Recursion to Participate in Upcoming Investor Conference","datePublished":"2025-04-01T13:37:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-to-participate-in-upcoming-investor-conference-5\/"},"wordCount":235,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-to-participate-in-upcoming-investor-conference-5\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNDQxMSM2ODQ0MTA5IzIyNTY0MTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-to-participate-in-upcoming-investor-conference-5\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-to-participate-in-upcoming-investor-conference-5\/","name":"Recursion to Participate in Upcoming Investor Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-to-participate-in-upcoming-investor-conference-5\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-to-participate-in-upcoming-investor-conference-5\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNDQxMSM2ODQ0MTA5IzIyNTY0MTY=","datePublished":"2025-04-01T13:37:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-to-participate-in-upcoming-investor-conference-5\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/recursion-to-participate-in-upcoming-investor-conference-5\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-to-participate-in-upcoming-investor-conference-5\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNDQxMSM2ODQ0MTA5IzIyNTY0MTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxNDQxMSM2ODQ0MTA5IzIyNTY0MTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/recursion-to-participate-in-upcoming-investor-conference-5\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Recursion to Participate in Upcoming Investor Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/832297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=832297"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/832297\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=832297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=832297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=832297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}